Aura Biosciences (AURA) Shares Outstanding (Weighted Average) (2020 - 2026)

Aura Biosciences has reported Shares Outstanding (Weighted Average) for 7 years, with the latest figure at $67.4 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 34.56% year-over-year to $67.4 million; the trailing twelve-month figure through Mar 2026 stood at $67.4 million (up 34.56% YoY), and the FY2025 full-year result was $7.4 million, down 85.1% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $67.4 million, up from $7.4 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $67.4 million in Q1 2026, with the low at $12686.0 in Q2 2022.
• Historically, Shares Outstanding (Weighted Average) has averaged $34.7 million across 5 years, with a median of $37.9 million in 2023.
• Annual changes were most pronounced in 2024 — Shares Outstanding (Weighted Average) sank 99.97% — and 2025, when it surged 519659.36%.
• Aura Biosciences' Shares Outstanding (Weighted Average) stood at $29.9 million in 2022, then soared by 32.34% to $39.6 million in 2023, then gained by 25.32% to $49.7 million in 2024, then slumped by 85.1% to $7.4 million in 2025, then surged by 811.68% to $67.4 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $67.4 million (Q1 2026), $7.4 million (Q4 2025), and $65.9 million (Q3 2025), per Business Quant data.